Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liposomal adjuvant development for leishmaniasis vaccines.
Askarizadeh A, Jaafari MR, Khamesipour A, Badiee A. Askarizadeh A, et al. Ther Adv Vaccines. 2017 Aug;5(4-5):85-101. doi: 10.1177/2051013617741578. Epub 2017 Nov 15. Ther Adv Vaccines. 2017. PMID: 29201374 Free PMC article. Review.
Development of nano-carriers for Leishmania vaccine delivery.
Askarizadeh A, Badiee A, Khamesipour A. Askarizadeh A, et al. Expert Opin Drug Deliv. 2020 Feb;17(2):167-187. doi: 10.1080/17425247.2020.1713746. Epub 2020 Jan 14. Expert Opin Drug Deliv. 2020. PMID: 31914821 Review.
The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre-insertion and post-insertion methods for brain delivery in normal mice.
Mehrabian A, Dadpour S, Mashreghi M, Zarqi J, Askarizadeh A, Badiee A, Arabi L, Moosavian SA, Jaafari MR. Mehrabian A, et al. Among authors: askarizadeh a. IET Nanobiotechnol. 2023 Apr;17(2):112-124. doi: 10.1049/nbt2.12111. Epub 2023 Jan 3. IET Nanobiotechnol. 2023. PMID: 36594666 Free PMC article.
A novel and easy to prepare azo-based bioreductive linker and its application in hypoxia-sensitive cationic liposomal doxorubicin: Synthesis, characterization, in vitro and in vivo studies in mice bearing C26 tumor.
Mashreghi M, Faal Maleki M, Askarizadeh A, Farshchi H, Farhoudi L, Nasrollahzadeh MS, Rezazade Bazaz M, Hadizadeh F, Jaafari MR. Mashreghi M, et al. Among authors: askarizadeh a. Chem Phys Lipids. 2022 Sep;247:105226. doi: 10.1016/j.chemphyslip.2022.105226. Epub 2022 Jul 15. Chem Phys Lipids. 2022. PMID: 35850240
16 results